Navigation Links
Nfocus Neuromedical Receives CE Mark for the CardioVasc(TM) Stent-Graft and Delivery System
Date:2/12/2008

oved in the United States.

Due to the large numbers of patients that have been helped by CABG surgery in past years, there is a large pool of patients with diseased SVG bypass vessels in need of this procedure.

For more information about Saphenous Vein Graft Disease see: http://www.americanheart.org

About Nfocus Neuromedical, Inc.

Nfocus is a neurovascular development, manufacturing and marketing company focused on treating hemorrhagic stroke. Current and future product programs are aimed at rapid treatment of aneurysms and fistulas in the brain. Nfocus also has developed the CardioVasc(TM) Stent-graft for specific applications within the coronary artery disease market. Based in Palo Alto, California, Nfocus is privately held and venture capital backed. See http://www.nfocusneuro.com for further information.


'/>"/>
SOURCE Nfocus Neuromedical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine news :

1. Lake Elsinore Family Caregiver Receives Free Power Wheelchair From The SCOOTER Store
2. DaVita Receives Civil Complaint
3. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
4. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
5. Edwards Lifesciences Receives CE Mark for Edwards SAPIEN Transcatheter Heart Valve
6. PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers
7. UT Southwesterns obesity research receives $22 million NIH Roadmap grant
8. Temple Emergency Medicine receives $1.8M to find best MRSA treatment
9. Prime Therapeutics Receives TIPPS Certification
10. Bioniche Receives $2 Million Government Grant For Market Development Related to its E. coli O157:H7 Cattle Vaccine
11. UCLA receives $22.5 million to explore the fundamental biology of mental disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)... Board Decision May Be Revealed Friday, January 9.../ -- Today, Service Employees International Union... call of the SEIU International Executive Board to...e and homecare members out of SEIU United Healthca..., but delayed the final decision until tomorrow. ,...
(Date:1/8/2009)... California Assembly Member Tom Torlakson Introduc...wire-USNewswire/ -- Today, Lung Cancer Alliance-...mber Tom Torlakson (D-11th District) for his conti...ng funding for lung cancer research. For the thir...ng cancer research is being considered in the Cali...
(Date:1/8/2009)... Results of St. Jude study could shape new treatme... Jan. 8 Scientists at S...ated a more effective treatment for bacterial pneu...ibiotics clindamycin and azithromycin, which kill ...e more effective than a standard first-line treatm...
(Date:1/8/2009)...y,re not quick to condemn hurtful comments, study ...y News) -- Many people overestimate how strongly t...dy says. , Sixty-three percent of study partic... to partner for an experiment with a white person ...er made racist comments about the black person whe...
Breaking Medicine News(10 mins):Health News:SEIU Decision to Force Transfer of Long-Term Care Members Out of United Healthcare Workers Delayed 2Health News:Lung Cancer Alliance Applauds New Legislation Funding Lung Cancer Research 2Health News:Study Finds More Effective Treatment for Pneumonia Following Influenza 2Health News:Study Finds More Effective Treatment for Pneumonia Following Influenza 3Health News:Many Turn Blind Eye to Racism 2
...e associated fat in the diet with obesity, diabete...leading to inflammatory conditions such as asthma.... of Garvan Institute at Sydney discovered a link b...iet and immunity. Researchers believed that this ...
... consume alcohol occasionally, tend to opt for sic...sed by alcohol.// Kenneth Pidd, from the National ...Flinders University works as a research officer; h... due alcohol related abseentism is $473 million as...
...overed by researchers at the University of North C... associated with two forms of pancreatic cancer//,... researchers. The gene, called palladin, was disco... and her former student, Dr. Mana Parast, now a pa...
... at the University of Edinburgh in Scotland say th...a,// a mental disorder that affects about 1% of pe...ished in the BioMed Central Medicine journal. The ...e, who were at a high risk of developing schizophr...
Other Medicine News:Health News:Gene Discovered by Researchers Tied to Pancreatic Cancer 2
(Date:1/7/2009)...e Preterm Infants Drive the Increase , , WHITE ...w government statistics confirm that the decades-l...ontinues, putting more infants than ever at increa...March of Dimes. , , Nearly 543,000 babies were ...enter for Health Statistics, which today released ...
(Date:1/7/2009)...JING, Jan. 7 Tiantan Puhua Hospita...m ), the worldwide leader in using stem cells to e... today six new globally experienced additions to i...xpand the hospital,s treatment capabilities for gr...The six senior doctors include the distinguished D...
(Date:1/6/2009)...ves significance of AHCC for maintaining a healthy...wswire/ -- A recently published study in Nutritio...ansai Medical University in Osaka, Japan has shown...ances immune function by increasing the number of ...mmune system responsible for presenting foreign su...
(Date:1/6/2009)...KVILLE, Md., Jan. 6 Seq...mpany focused on diseases of epidemic potential, a... for the treatment of tuberculosis (TB), was the f...ed clinical program contract to Dynport Vaccine Co...t, awarded by the National Institute of Allergy an...
Breaking Medicine Technology:Preterm Births Rise 36 Percent Since Early 1980s 2Stem Cell Treatment Leader Tiantan Puhua Adds Experienced International Medical Staff for Expanding Numbers of Patients 2Stem Cell Treatment Leader Tiantan Puhua Adds Experienced International Medical Staff for Expanding Numbers of Patients 3Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells 2Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells 3Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 2Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 3Cardiome And Astellas Announce Regulatory Update 9815 1Cardiome And Astellas Announce Regulatory Update 9815 2Cardiome And Astellas Announce Regulatory Update 9815 3Cardiome And Astellas Announce Regulatory Update 9815 4Study looks at off label use of biliary stents 9812 1Study looks at off label use of biliary stents 9812 2NEWSWEEK 3A Media Lead Sheet January 28 2008 Issue 28on newsstands Monday January 21 29 9809 1NEWSWEEK 3A Media Lead Sheet January 28 2008 Issue 28on newsstands Monday January 21 29 9809 2NEWSWEEK 3A Media Lead Sheet January 28 2008 Issue 28on newsstands Monday January 21 29 9809 3NEWSWEEK 3A Media Lead Sheet January 28 2008 Issue 28on newsstands Monday January 21 29 9809 4NEWSWEEK 3A Media Lead Sheet January 28 2008 Issue 28on newsstands Monday January 21 29 9809 5Scientists identify genes linked to lupus in women 9805 1Scientists identify genes linked to lupus in women 9805 2
...l/ -- Anadys,Pharmaceuticals, Inc. , a biopharmace...ment and commercialization of novel medicines,for ...oday that it,has nominated ANA598 as a candidate f...direct antiviral for the treatment of chronic,hepa...ed a small-molecule, non-nucleoside inhibitor,of t...
...- Millipore Corporation today announced the releas...ell lines. The,research was conducted by the Depa...and ReNeuron Group plc, whose ReNcell,distribution...The data will be presented by Dr. Vi Chu, research... Bioprocess Division, in,a technology talk at the ...
Other Medicine Technology:Anadys Pharmaceuticals Nominates ANA598, a Small-Molecule,Non-Nucleoside Inhibitor of The NS5b Polymerase, as a Candidate for,Clinical Development in Chronic Hepatitis C Virus Infection 2Anadys Pharmaceuticals Nominates ANA598, a Small-Molecule,Non-Nucleoside Inhibitor of The NS5b Polymerase, as a Candidate for,Clinical Development in Chronic Hepatitis C Virus Infection 3Anadys Pharmaceuticals Nominates ANA598, a Small-Molecule,Non-Nucleoside Inhibitor of The NS5b Polymerase, as a Candidate for,Clinical Development in Chronic Hepatitis C Virus Infection 4Millipore Corporation Announces New ReNcell Data from Collaboration,with ReNeuron 2Millipore Corporation Announces New ReNcell Data from Collaboration,with ReNeuron 3Millipore Corporation Announces New ReNcell Data from Collaboration,with ReNeuron 4
This device is a qualitative immunoassay intended to be used to inspect the,overdose usage of cocaine by detecting the benzoylecgonine, a metabolite of,cocaine, in human urine at a cutoff level of 30
...d, user-friendly system that helps high volume lab...e. This state-of-the-art system provides clotting,...ilities with a complete menu of routine and specia... that offers 24-hour, 7-day continuous operation w...
...produced with recombinant technology, that have be... are capable of detecting the different types of T...with amino acid sequences repeated in tandem. SAPA...ute phase of the infection, it reacts with 93% of ...
Inquire
Medicine Products: